Membership
Tour
Register
Log in
HETEROCYCLIC COMPOUNDS
Follow
Industry
CPC
C07D
Parent Industries
C
CHEMISTRY METALLURGY
C07
Organic chemistry
Current Industry
C07D
HETEROCYCLIC COMPOUNDS
Sub Industries
C07D201/00
Preparation, separation, purification or stabilisation of unsubstituted lactams
C07D203/00
Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
C07D205/00
Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
C07D207/00
Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
C07D209/00
Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
C07D211/00
Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
C07D213/00
Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
C07D215/00
Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
C07D217/00
Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
C07D219/00
Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
C07D221/00
Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
C07D223/00
Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
C07D225/00
Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
C07D227/00
Heterocyclic compounds containing rings having one nitrogen atom as the only ring hetero atom, according to more than one of groups C07D203/00 - C07D225/00
C07D229/00
Heterocyclic compounds containing rings of less than five members having two nitrogen atoms as the only ring hetero atoms
C07D231/00
Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
C07D233/00
Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
C07D235/00
Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
C07D237/00
Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
C07D239/00
Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
C07D241/00
Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
C07D243/00
Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
C07D245/00
Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms
C07D247/00
Heterocyclic compounds containing rings having two nitrogen atoms as the only ring hetero atoms, according to more than one of groups C07D229/00 - C07D245/00
C07D249/00
Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
C07D251/00
Heterocyclic compounds containing 1,3,5-triazine rings
C07D253/00
Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
C07D255/00
Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00
C07D257/00
Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
C07D259/00
Heterocyclic compounds containing rings having more than four nitrogen atoms as the only ring hetero atoms
C07D261/00
Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
C07D263/00
Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
C07D265/00
Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
C07D267/00
Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
C07D269/00
Heterocyclic compounds containing rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms according to more than one of groups C07D261/00 - C07D267/00
C07D271/00
Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
C07D273/00
Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
C07D275/00
Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
C07D277/00
Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
C07D279/00
Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
C07D281/00
Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
C07D283/00
Heterocyclic compounds containing rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms, according to more than one of groups C07D275/00 - C07D281/00
C07D285/00
Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
C07D291/00
Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms
C07D293/00
Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms
C07D295/00
Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicylo [3.2.2.] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
C07D301/00
Preparation of oxiranes
C07D303/00
Compounds containing three-membered rings having one oxygen atom as the only ring heteroatom
C07D305/00
Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atom
C07D307/00
Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
C07D309/00
Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
C07D311/00
Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
C07D313/00
Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
C07D315/00
Heterocyclic compounds containing rings having one oxygen atom as the only ring hetero atom according to more than one of groups C07D303/00 - C07D313/00
C07D317/00
Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
C07D319/00
Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
C07D321/00
Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
C07D323/00
Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms
C07D325/00
Heterocyclic compounds containing rings having oxygen as the only ring hetero atoms according to more than one of the main groups C07D303/00 - C07D323/00
C07D327/00
Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
C07D329/00
Heterocyclic compounds containing rings having oxygen and selenium or oxygen and tellurium atoms as the only ring hetero atoms
C07D331/00
Heterocyclic compounds containing rings of less than five members, having one sulfur atom as the only ring hetero atom
C07D333/00
Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
C07D335/00
Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
C07D337/00
Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom
C07D339/00
Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
C07D341/00
Heterocyclic compounds containing rings having three or more sulfur atoms as the only ring hetero atoms
C07D343/00
Heterocyclic compounds containing rings having sulfur and selenium or sulfur and tellurium atoms as the only ring hetero atoms
C07D345/00
Heterocyclic compounds containing rings having selenium or tellurium atoms as the only ring hetero atoms
C07D347/00
Heterocyclic compounds containing rings having halogen atoms as ring hetero atoms
C07D401/00
Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
C07D403/00
Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
C07D405/00
Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
C07D407/00
Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
C07D409/00
Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
C07D411/00
Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
C07D413/00
Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
C07D415/00
Heterocyclic compounds containing the thiamine skeleton
C07D417/00
Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
C07D419/00
Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms
C07D421/00
Heterocyclic compounds containing two or more hetero rings, at least one ring having selenium, tellurium, or halogen atoms as ring hetero atoms
C07D451/00
Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems
C07D453/00
Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems
C07D455/00
Heterocyclic compounds containing quinolizine ring systems
C07D457/00
Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems
C07D459/00
Heterocyclic compounds containing benz [g] indolo [2, 3-a] quinolizine ring systems
C07D461/00
Heterocyclic compounds containing indolo [3,2,1-d,e] pyrido [3,2,1,j] [1,5]-naphthyridine ring systems
C07D463/00
Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:
C07D471/00
Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
C07D473/00
Heterocyclic compounds containing purine ring systems
C07D475/00
Heterocyclic compounds containing pteridine ring systems
C07D477/00
Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , carbapenicillins, thienamycins Such ring systems being further condensed
C07D487/00
Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00
C07D489/00
Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems
C07D491/00
Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
C07D493/00
Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
C07D495/00
Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
C07D497/00
Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms
C07D498/00
Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
C07D499/00
Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:
C07D501/00
Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:
C07D503/00
Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:
C07D505/00
Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:
C07D507/00
Heterocyclic compounds containing a condensed beta-lactam ring system, not provided for by groups C07D463/00, C07D477/00 or C07D499/00 - C07D505/00 Such ring systems being further condensed
C07D513/00
Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
C07D515/00
Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
C07D517/00
Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium or halogen atoms as ring hetero atoms
C07D519/00
Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
C07D521/00
Heterocyclic compounds containing unspecified hetero rings
Industries
Overview
Organizations
People
Information
Impact
Patents Grants
last 30 patents
Information
Patent Grant
Imidazopyrazine derivatives, process for preparation thereof, and t...
Patent number
11,938,199
Issue date
Mar 26, 2024
Institut Pasteur
Yves-Louis Janin
G01 - MEASURING TESTING
Information
Patent Grant
Benzolactam compounds as protein kinase inhibitors
Patent number
11,939,321
Issue date
Mar 26, 2024
Otsuka Pharmaceutical Co., Ltd.
Valerio Berdini
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Heterocyclic compounds
Patent number
11,939,327
Issue date
Mar 26, 2024
Takeda Pharmaceutical Company Limited
Tomoaki Hasui
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Solid forms of isoquinolinones, and process of making, composition...
Patent number
11,939,333
Issue date
Mar 26, 2024
Infinity Pharmaceuticals, Inc.
Louis Grenier
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Spiropyran composite having improved mechano-sensitivity, method fo...
Patent number
11,939,338
Issue date
Mar 26, 2024
Korea Institute of Science and Technology
Jaewoo Kim
C08 - ORGANIC MACROMOLECULAR COMPOUNDS THEIR PREPARATION OR CHEMICAL WORKING-...
Information
Patent Grant
Coordination zirconium phosphotungstate catalyst and its applicatio...
Patent number
11,938,465
Issue date
Mar 26, 2024
Jiangnan University
Liping Zhang
C01 - INORGANIC CHEMISTRY
Information
Patent Grant
Catalyst system for producing cyclic carbonates and method related...
Patent number
11,938,468
Issue date
Mar 26, 2024
PTT Exploration and Production Public Company Limited
Taradon Piromchart
B01 - PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
Information
Patent Grant
LPA receptor antagonists and uses thereof
Patent number
11,939,318
Issue date
Mar 26, 2024
Gilead Sciences, Inc.
Brian P. Bestvater
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Diamine compound and organic light-emitting device including the same
Patent number
11,944,006
Issue date
Mar 26, 2024
Samsung Display Co., Ltd.
Jongwoo Kim
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Compound, material for organic electroluminescent element, organic...
Patent number
11,944,009
Issue date
Mar 26, 2024
Idemitsu Kosan Co., Ltd.
Keiichi Yasukawa
C09 - DYES PAINTS POLISHES NATURAL RESINS ADHESIVES MISCELLANEOUS COMPOSITION...
Information
Patent Grant
Metalloenzyme inhibitor compounds
Patent number
11,938,134
Issue date
Mar 26, 2024
Eikonizo Therapeutics, Inc.
Christopher M. Yates
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
6-(3-hydroxyphenyl)-2-methoxy-4-(3-methylphenyl)nicotinonitrile as...
Patent number
11,939,295
Issue date
Mar 26, 2024
KING FAISAL UNIVERSITY
Mai Mostafa Khalaf Ali
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
5-(4,5-bis(4-bromophenyl)-2-(4-chlorophenyl)-1H-imidazol-1-yl)penta...
Patent number
11,939,298
Issue date
Mar 26, 2024
KING FAISAL UNIVERSITY
Hany Mohamed Abd El-Lateef Ahmed
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Ethyl 6-(5-(3-fluorophenyl)-4-phenyl-4H-1,2,4-triazol-3-ylthio)hexa...
Patent number
11,939,304
Issue date
Mar 26, 2024
KING FAISAL UNIVERSITY
Mai Mostafa Khalaf Ali
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Acid-labile surfactants
Patent number
11,939,311
Issue date
Mar 26, 2024
Promega Corporation
Joel Walker
G01 - MEASURING TESTING
Information
Patent Grant
Enantiomeric entactogen compositions and their use
Patent number
11,939,312
Issue date
Mar 26, 2024
Arcadia Medicine, Inc.
Nikita Obidin
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Molecule having pesticidal utility, and compositions, and processes...
Patent number
11,939,313
Issue date
Mar 26, 2024
CORTEVA AGRISCIENCE LLC
Yu Zhang
A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information
Patent Grant
Quinolin-2-one derivatives
Patent number
11,939,314
Issue date
Mar 26, 2024
Merck Patent GmbH
Dieter Dorsch
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
9-(6-flouro-2-hydroxyouinolin-3-yl)-10-(2-hydroxyethyl)-3,6-dipheny...
Patent number
11,939,316
Issue date
Mar 26, 2024
KING FAISAL UNIVERSITY
Hany Mohamed Abd El-Lateef Ahmed
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Method for producing tetracyclic compound
Patent number
11,939,322
Issue date
Mar 26, 2024
CHUGAI SEIYAKU KABUSHIKI KAISHA
Hiroki Serizawa
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Process for making biologically active compounds and intermediates...
Patent number
11,939,325
Issue date
Mar 26, 2024
MAKSCIENTIFIC, LLC
Alexandros Makriyannis
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Synthesis of coelenterazine
Patent number
11,939,332
Issue date
Mar 26, 2024
International Paper Company
Rajagopala Reddy Duvvuru
B01 - PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
Information
Patent Grant
Materials for organic electroluminescent devices
Patent number
11,939,339
Issue date
Mar 26, 2024
Merck Patent GmbH
Rouven Linge
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
CDK inhibitors and their use as pharmaceuticals
Patent number
11,939,340
Issue date
Mar 26, 2024
Prelude Therapeutics Incorporated
Jincong Zhuo
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Process for the preparation of midostaurin with high purity
Patent number
11,939,342
Issue date
Mar 26, 2024
Procos S.p.A.
Alberto Lena
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Liquid crystal mixture and liquid crystal display
Patent number
11,939,511
Issue date
Mar 26, 2024
Merck Patent GmbH
Lars Lietzau
C09 - DYES PAINTS POLISHES NATURAL RESINS ADHESIVES MISCELLANEOUS COMPOSITION...
Information
Patent Grant
Lipid prodrugs of mycophenolic acid and uses thereof
Patent number
11,938,137
Issue date
Mar 26, 2024
PureTech LYT, Inc.
Daniel Kenneth Bonner
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Bacterial efflux pump inhibitors
Patent number
11,938,114
Issue date
Mar 26, 2024
Rutgers, The State University of New Jersey
Edmond J. LaVoie
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Cross-linked polycarboxylated polysaccharides and methods of use th...
Patent number
11,939,409
Issue date
Mar 26, 2024
HALLURA LTD.
Stephane Meunier
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
GRP94 selective inhibitors and uses thereof
Patent number
11,939,291
Issue date
Mar 26, 2024
University of Kansas
Sanket Jaiprakash Mishra
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Patents Applications
last 30 patents
Information
Patent Application
PHARMACEUTICALLY ACCEPTABLE SALTS AND COMPOSITIONS THEREOF
Publication number
20240101514
Publication date
Mar 28, 2024
Beckley Psytech Limited
Jason GRAY
C07 - ORGANIC CHEMISTRY
Information
Patent Application
SALT OF OMECAMTIV MECARBIL AND PROCESS FOR PREPARING SALT
Publication number
20240101517
Publication date
Mar 28, 2024
Cytokinetics, Inc.
Sheng CUI
C07 - ORGANIC CHEMISTRY
Information
Patent Application
A METHOD FOR PREPARATION OF 1-(2-((2,4-DIMETHYLPHENYL)THIO)PHENYL)...
Publication number
20240101524
Publication date
Mar 28, 2024
R L FINE CHEM PRIVATE LIMITED
Vinay KUMAR
B01 - PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
Information
Patent Application
SUBSTITUTED PYRAZOLO PIPERIDINE CARBOXYLIC ACIDS
Publication number
20240101528
Publication date
Mar 28, 2024
Alexandros VAKALOPOULOS
C07 - ORGANIC CHEMISTRY
Information
Patent Application
METHODS AND INTERMEDIATES FOR PREPARING THERAPEUTIC COMPOUNDS
Publication number
20240101533
Publication date
Mar 28, 2024
GILEAD SCIENCES, INC.
Kevin McCormack Allan
C07 - ORGANIC CHEMISTRY
Information
Patent Application
NOVEL BENZOXAZINE COMPOUND, RESIN RAW MATERIAL COMPOSITION CONTAINI...
Publication number
20240101543
Publication date
Mar 28, 2024
Honshu Chemical Industry Co., Ltd.
Yoshimi UTAKA
C08 - ORGANIC MACROMOLECULAR COMPOUNDS THEIR PREPARATION OR CHEMICAL WORKING-...
Information
Patent Application
SUBSTITUTED NICOTINIMIDE INHIBITORS OF BTK FOR TREATING CANCER
Publication number
20240101545
Publication date
Mar 28, 2024
GUANGZHOU INNOCARE PHARMA TECH CO., LTD.
Xiangyang CHEN
C07 - ORGANIC CHEMISTRY
Information
Patent Application
METHOD FOR PREPARING 2-[2-(2-CHLOROTHIAZOL-5-YL)-2-OXO-ETHYL]SULFAN...
Publication number
20240101547
Publication date
Mar 28, 2024
BASF SE
Christopher Koradin
C07 - ORGANIC CHEMISTRY
Information
Patent Application
TRICYCLIC KINASE INHIBITORS AND USES THEREOF
Publication number
20240101559
Publication date
Mar 28, 2024
Dana-Farber Cancer Institute, Inc.
Nathanael S. Gray
C07 - ORGANIC CHEMISTRY
Information
Patent Application
NITROGENOUS HETEROAROMATIC COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT...
Publication number
20240101560
Publication date
Mar 28, 2024
Merck Patent GmbH
Philipp STOESSEL
C07 - ORGANIC CHEMISTRY
Information
Patent Application
SALT CRYSTALS
Publication number
20240101569
Publication date
Mar 28, 2024
INTRA-CELLULAR THERAPIES, INC
Peng LI
C07 - ORGANIC CHEMISTRY
Information
Patent Application
New Pyridine And Pyrimidine Substituted Triazine UV Absorbers
Publication number
20240102236
Publication date
Mar 28, 2024
HUNTSMAN ADVANCED MATERIALS (SWITZERLAND) GMBH
Hosuk Ryu
D06 - TREATMENT OF TEXTILES OR THE LIKE LAUNDERING FLEXIBLE MATERIALS NOT OTH...
Information
Patent Application
N-ACRYLOYLINDOLES AND METHODS OF USE
Publication number
20240103005
Publication date
Mar 28, 2024
The University of Hong Kong
Yik Sham Clive CHUNG
G01 - MEASURING TESTING
Information
Patent Application
PHOTOCHROMIC COMPOSITION, PHOTOCHROMIC ARTICLE, AND SPECTACLES
Publication number
20240103200
Publication date
Mar 28, 2024
Hoya Lens Thailand Ltd.
Hironori KAWAKAMI
C07 - ORGANIC CHEMISTRY
Information
Patent Application
Nonaqueous Electrolytic Solution, Nonaqueous Electrolytic Solution...
Publication number
20240105992
Publication date
Mar 28, 2024
Central Glass Company, Limited
Ryosuke TERADA
H01 - BASIC ELECTRIC ELEMENTS
Information
Patent Application
HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING...
Publication number
20240107788
Publication date
Mar 28, 2024
LT MATERIALS CO., LTD.
Gi-Back LEE
C07 - ORGANIC CHEMISTRY
Information
Patent Application
ORGANIC ELECTROLUMINESCENCE DEVICE
Publication number
20240107876
Publication date
Mar 28, 2024
Idemitsu Kosan Co.,Ltd
Hiroaki TOYOSHIMA
C07 - ORGANIC CHEMISTRY
Information
Patent Application
HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAM...
Publication number
20240107878
Publication date
Mar 28, 2024
LT MATERIALS CO., LTD.
Eui-Jeong CHOI
C07 - ORGANIC CHEMISTRY
Information
Patent Application
ORGANIC LIGHT EMITTING DEVICE
Publication number
20240107884
Publication date
Mar 28, 2024
LG CHEM, LTD.
Minjun KIM
C07 - ORGANIC CHEMISTRY
Information
Patent Application
PROTEIN-PROTEIN INTERACTION MODULATORS OF AURORA KINASE A AND THEIR...
Publication number
20240101538
Publication date
Mar 28, 2024
Eberhard-Karls-Universitat Tubingen
Juliander J. REINER
C07 - ORGANIC CHEMISTRY
Information
Patent Application
POTENT ASGPR-BINDING COMPOUNDS FOR THE DEGRADATION OF IMMUNOGLOBULI...
Publication number
20240101539
Publication date
Mar 28, 2024
Avilar Therapeutics, Inc.
Jason Allan Wiles
C07 - ORGANIC CHEMISTRY
Information
Patent Application
TARGETED PROTEIN DEGRADATION OF PARP14 FOR USE IN THERAPY
Publication number
20240101540
Publication date
Mar 28, 2024
Ribon Therapeutics, Inc.
Nicholas Robert Perl
C07 - ORGANIC CHEMISTRY
Information
Patent Application
HETEROARYL-ACETYLENES, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THE...
Publication number
20240101546
Publication date
Mar 28, 2024
Sheldon Cao
C07 - ORGANIC CHEMISTRY
Information
Patent Application
HYDROXAMATE COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION T...
Publication number
20240101548
Publication date
Mar 28, 2024
SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.
Wei Wang
C07 - ORGANIC CHEMISTRY
Information
Patent Application
KRAS G12C INHIBITORS
Publication number
20240101553
Publication date
Mar 28, 2024
Mirati Therapeutics, Inc.
Matthew Arnold MARX
C07 - ORGANIC CHEMISTRY
Information
Patent Application
SALTS OF A PI3Kdelta INHIBITOR, CRYSTALLINE FORMS, METHODS OF PREPA...
Publication number
20240101564
Publication date
Mar 28, 2024
BEIGENE SWITZERLAND GMBH
Jing LI
C07 - ORGANIC CHEMISTRY
Information
Patent Application
DIHYDROOXADIAZINONE COMPOUND AND PHARMACEUTICAL USE THEREOF
Publication number
20240101572
Publication date
Mar 28, 2024
Japan Tobacco Inc.
Masahiro YOKOTA
C07 - ORGANIC CHEMISTRY
Information
Patent Application
MACROCYCLIC K-RAS G12C INHIBITOR, PREPARATION METHOD THEREFOR AND U...
Publication number
20240101573
Publication date
Mar 28, 2024
Abbisko Therapeutics Co., Ltd.
Guoliang XUN
C07 - ORGANIC CHEMISTRY
Information
Patent Application
METHODS AND COMPOSITIONS FOR MODULATING GENE EXPRESSION
Publication number
20240100191
Publication date
Mar 28, 2024
Wisconsin Alumni Research Foundation
Aseem Ansari
C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information
Patent Application
RADIOLABELLED MGL PET LIGANDS
Publication number
20240100198
Publication date
Mar 28, 2024
Janssen Pharmaceutica N.V.
Gang Chen
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE